Should anthracyclines and dexrazoxane be used for children with cancer?

Elvira C. van Dalen; Henk van den Berg; Martine F. Raphaël; Huib N. Caron; Leontien C. Kremer

doi:10.1016/S1470-2045(10)70301-6

Should anthracyclines and dexrazoxane be used for children with cancer?

Elvira C. van Dalen
, Henk van den Berg
, Martine F. Raphaël
, Huib N. Caron
, Leontien C. Kremer

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	12-13
Journal	lancet oncology
Volume	12
Issue number	1
DOIs	https://doi.org/10.1016/S1470-2045(10)70301-6
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S1470-2045(10)70301-6

Cite this

@article{08c63aa2d5d7401b903b8422d94d6ed2,

title = "Should anthracyclines and dexrazoxane be used for children with cancer?",

author = "\{van Dalen\}, \{Elvira C.\} and \{van den Berg\}, Henk and Rapha{\"e}l, \{Martine F.\} and Caron, \{Huib N.\} and Kremer, \{Leontien C.\}",

year = "2011",

doi = "10.1016/S1470-2045(10)70301-6",

language = "English",

volume = "12",

pages = "12--13",

journal = "lancet oncology",

issn = "1470-2045",